CCS and mesenchymal cell neoplasm: It was noted that circ-CCS could downregulate ATG10 by targeting miR-197-3P, and the autophagy-promoting effect of circ-CCS on mesenchymal tumor cells was reversed after knockdown of miR-197-3p (Sui et al., 2022).